THE following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
New drug helps COVID-19 patients breathe on their own
When a new monoclonal antibody drug was added to treatments being given to hospitalized COVID-19 patients who were still breathing on their own, the drug - lenzilumab from Humanigen Inc - significantly improved their odds of not needing invasive mechanical ventilation, researchers found. The 540 patients in the randomized trial were already receiving a variety of standard treatments. Half of them also received lenzilumab via three intravenous infusions. In a paper posted on Wednesday on medRxiv ahead of peer review, the research team reported that patients in the lenzilumab group had a 54% better chance of surviving without needing mechanical ventilation. In patients receiving steroids and Gilead Sciences antiviral drug remdesivir, the addition of lenzilumab improved survival without the need for mechanical ventilation by 92%. In patients under age 85 whose immune system was in the early stages of triggering a life-threatening inflammatory response, lenzilumab improved the odds of ventilator-free survival by nearly three-fold. Humanigen Chief Executive and study coauthor Dr. Cameron Durrant said his team believes the results "indicate a substantial improvement in COVID-19 treatment."
Virus might insert genetic fragments into patients' genetic code
A controversial new paper based on laboratory experiments suggests a possible explanation for why some COVID-19 survivors still test positive on viral RNA tests months later. Small fragments of genetic instructions from the coronavirus might get integrated into infected cells' genome. In the experiments, the fragments that got inserted into the cell's genetic code came mainly from the tail-end of the viral genome and cannot induce the cell to create infectious virus. However, they might be enough to trigger a positive result on COVID-19 PCR tests. "There is no evidence that the process of these integrations into the genome causes harm," said study leader Rudolf Jaenisch of the Whitehead Institute for Biomedical Research at MIT, adding that the researchers believe that is very unlikely. Other experts have said the findings, reported on Thursday in the journal PNAS, likely reflect unintended effects of experimental methods. The researchers have so far seen the phenomenon only in test tubes. They are trying to find direct evidence for SARS-CoV-2 sequences integrated into the genome in patients, "but these experiments are technically very challenging," Jaenisch said. The vaccines from Pfizer/BioNTech BNTX.O> and Moderna use messenger RNA to teach cells to make a protein that resembles a site on the virus. But the cell quickly breaks down the RNA and gets rid of it. "There is no evidence that vaccine RNA could integrate and we believe that this is highly unlikely," Jaenisch said. The high risks of complications from COVID-19 "would be a very strong incentive to get the vaccine," he said, citing negligible risk from the shots.
Home monitoring may keep COVID-19 patients out of hospital
A home monitoring program for patients with COVID-19 may be associated with lower odds of hospitalization, according to a new study. At the Cleveland Clinic, doctors remotely monitored 3,975 COVID-19 patients for up to 14 days after a positive test. In a study published on Thursday in JAMA Health Forum, they compared patterns of healthcare use by these patients and by 3,221 similar patients who did not participate in the program. A month after diagnosis, participants in the home monitoring program were 27% less likely than nonparticipants to have been hospitalized, although they had about a two-fold higher likelihood of outpatient visits with the home monitoring program. "As the pandemic continued and we learned more and more about the outcomes of the program, and the natural course of COVID infections in groups of patients, we were able to fine tune the program to those with highest risk," said Dr. Anita Misra-Hebert, director of the Clinic's Healthcare Delivery & Implementation Science Center. The trial was not randomized and does not provide conclusive evidence of the program's value. Instead, the researchers write, the results "support the need for randomized trials to evaluate home monitoring programs ... after COVID-19 diagnosis."
Reuters
Tue May 11 2021
A controversial new paper based on laboratory experiments suggests a possible explanation for why some COVID-19 survivors still test positive on viral RNA tests months later. Filepic/AP
Isu ladang musang king: Polis kenal pasti wakil rakyat untuk bantu siasatan
Polis kini sedang mengambil keterangan beberapa individu berhubung insiden menghalang penjawat awam menjalankan tugas ketika operasi penguatkuasaan di hutan simpan di Raub.
KHSB tawar 2,340 unit teres di bawah projek Rumah Selangorku di Bernam Jaya
Sebanyak 2,340 unit rumah teres akan dibangunkan di bawah projek Rumah Selangorku berskala besar pertama di negeri ini dikenali sebagai Lagenda Ardea.
Pelaburan AI perlu dimanfaatkan di setiap peringkat masyarakat
Menurut Profesor Rangkaian Komputer dan Keselamatan Siber Fakulti Sains Komputer dan Teknologi Maklumat, UPM, Prof. TS. Dr Zuriati Ahmad Zukarnain, inisiatif ini telah disusun untuk memberi panduan yang jelas dalam sokongan terhadap ekosistem pembangunan dan penggunaan teknologi AI negara.
Mesyuarat kaji penubuhan rangkaian 5G kedua Selasa depan
Ahli Lembaga Pengarah Digital Nasional BHD (DNB) akan mengadakan mesyuarat pada minggu depan bagi mengkaji laporan usaha wajar berkaitan penubuhan rangkaian 5G kedua.
DNB, Ericsson bekerjasama memangkinkan pendigitalan
Kerjasama itu menandakan inisiatif industri perintis yang akan membuka jalan kepada teknologi termaju untuk membolehkan pendigitalan perusahaan merentas pelbagai industri berbeza dan memacu Malaysia ke hadapan sebagai negara digital terkemuka.
Malaysia mungkin perlu import lebih banyak gas
Malaysia mungkin berdepan keperluan mengimport lebih banyak gas bagi tujuan penjanaan tenaga elektrik pada tahun-tahun akan datang sekiranya terus bergantung kepada komoditi itu tanpa usaha mempercepat peralihan kepada tenaga lebih lestari.
Maybank Research turunkan unjuran pertumbuhan KDNK Thailand kepada 2.4 peratus
Maybank Research Pte Ltd, Singapura telah menurunkan unjuran Keluaran Dalam Negara Kasar (KDNK) 2024 Thailand kepada 2.4 peratus daripada 2.9 peratus disebabkan oleh aktiviti pembuatan yang kurang memberangsangkan
Unjuran KDNK Malaysia dijangka berkembang pada 2024
Kenanga Investment Bank Bhd mengekalkan unjuran Keluaran Dalam Negara Kasar (KDNK) Malaysia akan berkembang pada 4.5 hingga 5.0 peratus pada 2024, berbanding 3.7 peratus tahun lalu, berikutan prestasi pembuatan yang lebih baik pada April.
Indeks kebebasan media: Saya terima laporan RSF dengan hati terbuka - Fahmi
Kedudukan Malaysia menurun 34 anak tangga dengan mencatat 52.07 mata berbanding tahun sebelumnya iaitu 62.83 mata.
Extra Joss umum tajaan rasmi Liga M, hangatkan kegilaan bola sepak tempatan
Minuman tenaga terkemuka Exra Joss mengumumkan tajaan rasminya bagi musim baharu Liga M melangkaui siaran dengan pengaktifan di lapangan stadium dan zon interaksi peminat interaktif bagi memastikan pengalaman jenama yang holistik.
Program Jana Wibawa dilaksana selepas dapat persetujuan Jemaah Menteri - Saksi
Mahkamah Sesyen di sini hari ini diberitahu bahawa cadangan mengenai Jana Wibawa telah dibawa ke mesyuarat untuk pertimbangan sebelum Jemaah Menteri memutuskan supaya program itu diteruskan pada 2020.
Kelaparan akut jejaskan 281.6 juta orang tahun lepas - PBB
Tahap bahaya kelaparan akut menjejaskan 281.6 juta orang tahun lepas, tahun kelima berturut-turut bahawa ketakjaminan makanan semakin memburuk.
Hamilton optimis kedudukan lebih baik di GP China
Lewis Hamilton melihat potensi kedudukan yang lebih baik dalam saingan Grand Prix yang kembali ke China buat pertama kali dalam tempoh lima tahun, hujung minggu ini.
'Selfish!' - Fasha Sandha sedih raya di Perlis tak jadi gara-gara dijangkiti COVID-19
Fasha berkata dia mula melakukan pemeriksaan COVID-19 selepas berasa tidak sihat badan dan mengalami bersin tidak henti sejak Raya pertama.
Kes COVID-19 catat penurunan ketara pada ME 14/2024 - KKM
Jumlah kes COVID-19 menurun 97.1 peratus kepada 493 kes pada Minggu Epidemiologi ke-14 (ME 14/2024) iaitu bagi tempoh 31 Mac hingga 6 April lepas berbanding 17,256 kes pada ME 1/2024.
China jadikan pengalaman pencegahan COVID-19 untuk hadapi pandemik masa depan
China akan menjadikan pengalaman dalam pencegahan dan kawalan COVID-19 untuk membuat persediaan yang lebih proaktif untuk menghadapi pandemik masa depan seperti "Penyakit X".
Negara berdepan ketirisan subsidi diesel serius - Amir Hamzah
Negara kini sedang berdepan isu ketirisan subsidi diesel yang serius dan wujud kemungkinan terdapat pihak yang tidak layak masih menikmati subsidi itu, kata Menteri Kewangan II Datuk Seri Amir Hamzah.
Kematian akibat kemalangan jalan raya lebih tinggi daripada COVID-19 - Anthony Loke
PDRM akan mengeluarkan data mengenai kemalangan jalan raya pada setiap hari, bukan setahun sekali seperti diamalkan sebelum ini.
Ismail Sabri ziarah lapan beradik yatim piatu akibat COVID-19
Ismail Sabri tiba kira-kira jam 2 petang di kediaman lapan beradik itu di Taman Adenium, Bukit Beruntung pada Selasa.
Teori konspirasi 'Penyakit X'
Ahli teori konspirasi AS sekali lagi membuat 'keuntungan' selepas PBB memberi amaran tentang wabak lebih berbahaya iaitu 'Penyakit X'.